Lowest Price Guaranteed
Pages
343
Last Updated
July 2026
View Count
18567
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Historical Evolution of Drug Delivery Devices
6.3. Conventional Parenteral Delivery
6.3.1. Needlestick Injuries
6.3.1.1. Incidence Rate and Cost Burden of Needlestick Injuries
6.4. Minimally Invasive Drug Delivery
6.4.1. Factors Influencing Growth of Minimally Invasive Drug Delivery Systems
6.4.1.1. Rising Burden of Chronic Diseases
6.4.1.2. Healthcare Cost Savings
6.4.1.3. Need for Immediate Treatment in Emergency Situations
6.4.1.4. Growing Injectable Drugs Market
6.4.1.5. Need for Improving Medication Adherence
6.5. Needle-free Injection Technology
6.5.1. Key Components of Needle-free Injection Systems
6.5.1.1. Injection Device
6.5.1.2. Nozzle
6.5.1.3. Pressure Source
6.6. Operating Mechanism of Needle-free Injection Systems
6.7. Classification based on Type of Load
6.7.1. Powder-based Injectors
6.7.2. Liquid-based Injectors
6.7.3. Depot or Projectile Injectors
6.8. Classification based on Actuation Mechanism
6.8.1. Spring Loaded Jet Injectors
6.8.2. Battery Powered Jet Injectors
6.8.3. Gas Powered Jet Injectors
6.8.4. Laser Powered Injectors
6.8.5. Lorentz Force-based Injectors
6.9. Microneedle Devices
6.9.1. Types of Microneedle Devices
6.9.2. Advantages of Microneedle Devices
6.9.3. Operating Mechanism of Microneedle Devices
6.10. Key Challenges related to Needle-free Injection Systems and Microneedle Devices
6.11. Recent Advancements
6.12. Future Perspectives
7. MARKET LANDSCAPE: NEEDLE-FREE INJECTION SYSTEMS
7.1 Chapter Overview
7.2. Needle-free Injection System Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Company Size and Location of Headquarters
7.3. Needle-free Injection Systems: Overall Market Landscape
7.3.1. Analysis by Actuation Mechanism
7.3.2. Analysis by Route of Administration
7.3.3. Analysis by Type of Formulation Administered
7.3.4. Analysis by Type of Drug Delivered
7.3.5. Analysis by Therapeutic Area
7.3.6. Analysis by Usability
7.3.7. Analysis by Type of Formulation Administered and Actuation Mechanism
8. MARKET LANDSCAPE: MICRONEEDLE DEVICES
8.1 Chapter Overview
8.2. Microneedle Device Providers: Overall Market Landscape
8.2.1. Analysis by Year of Establishment
8.2.2. Analysis by Company Size
8.2.3. Analysis by Location of Headquarters
8.2.4. Analysis by Company Size and Location of Headquarters
8.3. Microneedle Devices: Overall Market Landscape
8.3.1. Analysis by Stage of Development
8.3.2. Analysis by Type of Microneedle
8.3.3. Analysis by Type of Formulation Administered
8.3.4. Analysis by Route of Administration
8.3.5. Analysis by Therapeutic Area
8.3.6. Analysis by Type of Drug Delivered
8.3.7. Analysis by Type of Microneedle and Type of Formulation Administered
9. PRODUCT COMPETITIVENESS ANALYSIS: NEEDLE-FREE INJECTION SYSTEMS
9.1 Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Product Competitiveness Analysis: Needle-free Injection Systems
9.4.1. Spring-based Needle-free Injection Systems
9.4.2. Gas-powered Needle-free Injection Systems
9.4.3. Other Needle-free Injection Systems
10. PRODUCT COMPETITIVENESS ANALYSIS: MICRONEEDLE DEVICES
10.1 Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.4. Product Competitiveness Analysis: Microneedle Devices
10.4.1. Dissolving Microneedle Devices
10.4.2. Hollow Microneedle Devices
10.4.3. Solid Microneedle Devices
10.4.4. Other Microneedle Devices
11. LIKELY DRUG CANDIDATES: NEEDLE-FREE INJECTION SYSTEMS
11.1 Chapter Overview
11.2. Marketed Drugs Candidates
11.2.1. Most Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.2. Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.3. Less Likely Candidates for Delivery via Needle-Free Injection Systems
11.2.4. Least Likely Candidates for Delivery via Needle-Free Injection Systems
11.3. Clinical Drug Candidates (Biologics)
11.3.1. Most Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.2. Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.3. Less Likely Candidates for Delivery via Needle-Free Injection Systems
11.3.4. Least Likely Candidates for Delivery via Needle-Free Injection Systems
12. LIKELY DRUG CANDIDATES: MICRONEEDLE DEVICES
12.1. Chapter Overview
12.2. Marketed Drugs Candidates
12.2.1. Most Likely Candidates for Delivery via Microneedle Devices
12.2.2. Likely Candidates for Delivery via Microneedle Devices
12.2.3. Less Likely Candidates for Delivery via Microneedle Devices
12.2.4. Least Likely Candidates for Delivery via Microneedle Devices
12.3. Clinical Drug Candidates (Biologics)
12.3.1. Most Likely Candidates for Delivery via Microneedle Devices
12. 3.2. Likely Candidates for Delivery via Microneedle Devices
12. 3.3. Less Likely Candidates for Delivery via Microneedle Devices
12. 3.4. Least Likely Candidates for Delivery via Microneedle Devices
13. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN NORTH AMERICA
13.1. Chapter Overview
13.2. Leading Needle-free Drug Delivery Device Providers in North America
13.2.1. Antares Pharma (Acquired by Halozyme)
13.2.1.1. Company Overview
13.2.1.2. Product Portfolio
13.2.1.3. Recent Development and Future Outlook
13.2.2. D’Antonio Consultants International
13.2.3. HNS International
13.2.4. INOVIO Pharmaceuticals
13.2.5. Medical International Technology
13.2.6. PharmaJet
13.2.7. Zogenix (acquired by UCB)
13.3. Other Leading Needle-free Drug Delivery Device Providers in North America
13.3.1. 3M
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.2. TheraJect
14. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN EUROPE
14.1. Chapter Overview
14.2. Leading Needle-free Drug Delivery Device Providers in Europe
14.2.1. INJEX Pharma
14.2.1.1. Company Overview
14.2.1.2. Product Portfolio
14.2.1.3. Recent Development and Future Outlook
14.3. Other Leading Needle-free Drug Delivery Device Providers in North America
14.3.1. Debiotech
14.3.1.2. Company Overview
14.3.1.3. Product Portfolio
14.3.2. Micropoint Technologies
14.3.3. Nemaura Pharma
15. COMPANY PROFILES: NEEDLE-FREE DRUG DELIVERY DEVICE PROVIDERS BASED IN ASIA-PACIFIC AND REST OF THE WORLD
15.1. Chapter Overview
15.2. Leading Needle-free Drug Delivery Device Providers in Asia-Pacific and Rest of the World
15.2.1. MIKA MEDICAL
15.2.1.1. Company Overview
15.2.1.2. Product Portfolio
15.2.1.3. Recent Development and Future Outlook
15.2.2. QS Medical Technology (Quinovare)
15.3. Other Leading Needle-free Drug Delivery Device Providers in North America
15.3.1. INCYTO
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.2. NanoPass Technologies
16. MEGATRENDS ANALYSIS
17. MARKET IMPACT ANALYSIS
17.1. Chapter Overview
17.2. Market Drivers
17.3. Market Restraints
17.4. Market Opportunities
17.5. Market Challenges
17.6. Conclusion
18. GLOBAL NEEDLE-FREE INJECTION SYSTEMS MARKET
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Global Needle-free Injection Systems Market, till 2035
18.3.1. Scenario Analysis
18.3.1.1. Conservative Scenario
18.3.1.2. Optimistic Scenario
18.4. Key Market Segmentations
19. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT TYPE
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Needle-free Injection Systems Market: Distribution by Product Type
19.3.1. Needle-free Injection Systems Market for Fillable Devices, till 2035
19.3.2. Needle-free Injection Systems Market for Prefilled Devices, till 2035
19.4. Data Triangulation and Validation
20. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY ACTUATION MECHANISM
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Needle-free Injection Systems Market: Distribution by Actuation Mechanism
20.3.1. Needle-free Injection Systems Market for Spring-powered Devices, till 2035
20.3.2. Needle-free Injection Systems Market for Compressed-gas Devices, till 2035
20.3.3. Needle-free Injection Systems Market for Other Devices, till 2035
20.4. Data Triangulation and Validation
21. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY PRODUCT USABILITY
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Needle-free Injection Systems Market: Distribution by Product Usability
21.3.1. Needle-free Injection Systems Market for Reusable Devices, till 2035
21.3.2. Needle-free Injection Systems Market for Disposable Devices, till 2035
21.4. Data Triangulation and Validation
22. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY TYPE OF LOAD
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Needle-free Injection Systems Market: Distribution by Type of Load
22.3.1. Needle-free Injection Systems Market for Liquid-based Devices, till 2035
22.3.2. Needle-free Injection Systems Market for Powder-based Devices, till 2035
22.3.3. Needle-free Injection Systems Market for Projectile / Depot-based Devices, till 2035
22.4. Data Triangulation and Validation
23. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY ROUTE OF ADMINISTRATION
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Needle-free Injection Systems Market: Distribution by Route of Administration
23.3.1. Needle-free Injection Systems Market for Subcutaneous Route, till 2035
23.3.2. Needle-free Injection Systems Market for Intramuscular Route, till 2035
23.3.3. Needle-free Injection Systems Market for Intradermal Route, till 2035
23.4. Data Triangulation and Validation
24. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY APPLICATION AREA
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Needle-free Injection Systems Market: Distribution by Application Area
24.3.1. Needle-free Injection Systems Market for Insulin Delivery, till 2035
24.3.2. Needle-free Injection Systems Market for Pain Management, till 2035
24.3.3. Needle-free Injection Systems Market for Dermatology, till 2035
24.3.4. Needle-free Injection Systems Market for Vaccination, till 2035
24.4. Data Triangulation and Validation
25. NEEDLE-FREE INJECTION SYSTEMS MARKET, BY GEOGRAPHY
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Needle-free Injection Systems Market: Distribution by Geography
25.3.1. Needle-free Injection Systems Market in North America, till 2035
25.3.1.1. Needle-free Injection Systems Market in the US, till 2035
25.3.1.2. Needle-free Injection Systems Market in Canada, till 2035
25.3.2. Needle-free Injection Systems Market in Europe, till 2035
25.3.2.1. Needle-free Injection Systems Market in Germany, till 2035
25.3.2.2. Needle-free Injection Systems Market in the UK, till 2035
25.3.2.3. Needle-free Injection Systems Market in France, till 2035
25.3.2.4. Needle-free Injection Systems Market in Italy, till 2035
25.3.2.5. Needle-free Injection Systems Market in Spain, till 2035
25.3.3. Needle-free Injection Systems Market in Asia-Pacific, till 2035
25.3.3.1. Needle-free Injection Systems Market in China, till 2035
25.3.3.2. Needle-free Injection Systems Market in India, till 2035
25.3.3.3. Needle-free Injection Systems Market in Japan, till 2035
25.3.3.4. Needle-free Injection Systems Market in Australia, till 2035
25.3.4. Needle-free Injection Systems Market in Middle East and North Africa, till 2035
25.3.4.1. Needle-free Injection Systems Market in Egypt, till 2035
25.3.4.2. Needle-free Injection Systems Market in Saudi Arabia, till 2035
25.3.4.3. Needle-free Injection Systems Market in Israel, till 2035
25.3.5. Needle-free Injection Systems Market in Latin America, till 2035
25.3.5.1. Needle-free Injection Systems Market in Brazil, till 2035
25.3.5.2. Needle-free Injection Systems Market in Mexico, till 2035
25.3.5.3. Needle-free Injection Systems Market in Argentina, till 2035
25.4. Data Triangulation and Validation
26. GLOBAL MICRONEEDLE DEVICES MARKET
26.1. Chapter Overview
26.2. Key Assumptions and Methodology
26.3. Global Microneedle Devices Market, till 2035
26.3.1. Scenario Analysis
26.3.1.1. Conservative Scenario
26.3.1.2. Optimistic Scenario
26.4. Key Market Segmentations
27. MICRONEEDLE DEVICES MARKET, BY TYPE OF MICRONEEDLE
27.1. Chapter Overview
27.2. Key Assumptions and Methodology
27.3. Microneedle Devices Market: Distribution by Type of Microneedle
27.3.1. Microneedle Devices Market for Hollow Microneedles, till 2035
27.3.2. Microneedle Devices Market for Solid Microneedles, till 2035
27.3.3. Microneedle Devices Market for Dissolving Microneedles, till 2035
27.3.4. Microneedle Devices Market for Coated Microneedles, till 2035
27.4. Data Triangulation and Validation
28. MICRONEEDLE DEVICES MARKET, BY TYPE OF MATERIAL USED
28.1. Chapter Overview
28.2. Key Assumptions and Methodology
28.3. Microneedle Devices Market: Distribution by Type of Material Used
28.3.1. Microneedle Devices Market for Polymer Microneedles, till 2035
28.3.2. Microneedle Devices Market for Silicon Microneedles, till 2035
28.3.3. Microneedle Devices Market for Metal Microneedles, till 2035
28.3.4. Microneedle Devices Market for Ceramic Microneedles, till 2035
28.4. Data Triangulation and Validation
29. MICRONEEDLE DEVICES MARKET, BY APPLICATION AREA
29.1. Chapter Overview
29.2. Key Assumptions and Methodology
29.3. Microneedle Devices Market: Distribution by Application Area
29.3.1. Microneedle Devices Market for Insulin Delivery, till 2035
29.3.2. Microneedle Devices Market for Pain Management, till 2035
29.3.3. Microneedle Devices Market for Vaccination, till 2035
29.3.4. Microneedle Devices Market for Oncology, till 2035
29.4. Data Triangulation and Validation
30. MICRONEEDLE DEVICES MARKET, BY TYPE OF INTERVENTION
30.1. Chapter Overview
30.2. Key Assumptions and Methodology
30.3. Microneedle Devices Market: Distribution by Type of Intervention
30.3.1. Microneedle Devices Market for Vaccines, till 2035
30.3.2. Microneedle Devices Market for Therapeutic Agents, till 2035
30.3.3. Microneedle Devices Market for Other Interventions, till 2035
30.4. Data Triangulation and Validation
31. MICRONEEDLE DEVICES MARKET, BY GEOGRAPHY
31.1. Chapter Overview
31.2. Key Assumptions and Methodology
31.3. Microneedle Devices Market: Distribution by Geography
31.3.1. Microneedle Devices Market in North America, till 2035
31.3.1.1. Microneedle Devices Market in the US, till 2035
31.3.1.2. Microneedle Devices Market in Canada, till 2035
31.3.1.3. Microneedle Devices Market in Rest of North America, till 2035
31.3.2. Microneedle Devices Market in Europe, till 2035
31.3.2.1. Microneedle Devices Market in France, till 2035
31.3.2.2. Microneedle Devices Market in Spain, till 2035
31.3.2.3. Microneedle Devices Market in the UK, till 2035
31.3.2.4. Microneedle Devices Market in Germany, till 2035
31.3.2.5. Microneedle Devices Market in Italy, till 2035
31.3.2.6. Microneedle Devices Market in Rest of Europe, till 2035
31.3.3. Microneedle Devices Market in Asia-Pacific, till 2035
31.3.3.1. Microneedle Devices Market in China, till 2035
31.3.3.2. Microneedle Devices Market in Japan, till 2035
31.3.3.3. Microneedle Devices Market in India, till 2035
31.3.3.4. Microneedle Devices Market in Australia, till 2035
31.3.3.5. Microneedle Devices Market in Rest of Asia-Pacific, till 2035
31.3.4. Microneedle Devices Market in Rest of the World, till 2035
31.4. Data Triangulation and Validation
32. CONCLUDING REMARKS
33. EXECUTIVE INSIGHTS
33.1. Chapter Overview
33.2. Portal Instruments
33.2.1. Company Snapshot
33.2.2. Interview Transcript
33.3. Vaxess Technologies
33.3.1. Company Snapshot
33.3.2. Interview Transcript
33.4. Innoture
33.4.1. Company Snapshot
33.4.2. Interview Transcript
34. APPENDIX I: TABULATED DATA
35. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Key Market Segmentation
Figure 3.3 Market Dynamics: Robust Quality Control
Figure 4.1 Lessons Learnt From Past Recessions
Figure 5.1 Executive Summary: Needle-free Injection Systems Market Landscape (I / II)
Figure 5.2 Executive Summary: Needle-free Injection Systems Market Landscape (II / II)
Figure 5.3 Executive Summary: Microneedle Devices Market Landscape (I / II)
Figure 5.4 Executive Summary: Microneedle Devices Market Landscape (II / II)
Figure 5.5 Executive Summary: Needle-free Injection Systems Market Sizing and Opportunity Analysis
Figure 5.6 Executive Summary: Microneedle Devices Market Sizing and Opportunity Analysis
Figure 6.1 Minimally Invasive Drug Delivery Systems: Driving Factors
Figure 6.2 Needle-free Jet Injectors: Key Components
Figure 6.3 Needle-free Jet Injection: Stages of Drug Delivery
Figure 6.4 Microneedle Devices: Drug Delivery Mechanism
Figure 7.1 Needle-free Injection System Providers: Distribution by Year of Establishment
Figure 7.2 Needle-free Injection System Providers: Distribution by Company Size
Figure 7.3 Needle-free Injection System Providers: Distribution by Location of Headquarters (Region)
Figure 7.4 Needle-free Injection System Providers: Distribution by Location of Headquarters (Country)
Figure 7.5 Needle-free Injection System Providers: Distribution by Company Size and Location of Headquarters (Region)
Figure 7.6 Needle-free Injection Systems: Distribution by Type of Actuation Mechanism
Figure 7.7 Needle-free Injection Systems: Distribution by Route of Administration
Figure 7.8 Needle-free Injection Systems: Distribution by Type of Formulation Administered
Figure 7.9 Needle-free Injection Systems: Distribution by Type of Drug Delivered
Figure 7.10 Needle-free Injection Systems: Distribution by Therapeutic Area
Figure 7.11 Needle-free Injection Systems: Distribution by Usability
Figure 7.12 Needle-free Injection Systems: Distribution by Type of Formulation Administered and Actuation Mechanism
Figure 8.1 Microneedle Device Providers: Distribution by Year of Establishment
Figure 8.2 Microneedle Device Providers: Distribution by Company Size
Figure 8.3 Microneedle Device Providers: Distribution by Location of Headquarters (Region)
Figure 8.4 Microneedle Device Providers: Distribution by Location of Headquarters (Country)
Figure 8.5 Microneedle Devices Providers: Distribution by Company Size and Location of Headquarters (Region)
Figure 8.6 Microneedle Devices: Distribution by Stage of Development
Figure 8.7 Microneedle Devices: Distribution by Type of Microneedle
Figure 8.8 Microneedle Devices: Distribution by Type of Formulation Administered
Figure 8.9 Microneedle Devices: Distribution by Route of Administration
Figure 8.10 Microneedle Devices: Distribution by Therapeutic Area
Figure 8.11 Microneedle Devices: Distribution by Type of Drug Delivered
Figure 8.12 Microneedle Devices: Distribution by Type of Microneedle and Formulation Administered
Figure 9.1 Product Competitiveness Analysis: Spring-based Needle-free Injection Systems
Figure 9.2 Product Competitiveness Analysis: Gas-powered Needle-free Injection Systems
Figure 9.3 Product Competitiveness Analysis: Other Needle-free Injection Systems
Figure 10.1 Product Competitiveness Analysis: Dissolving Microneedle Devices
Figure 10.2 Product Competitiveness Analysis: Hollow Microneedle Devices
Figure 10.3 Product Competitiveness Analysis: Solid Microneedle Devices
Figure 10.4 Product Competitiveness Analysis: Other Microneedle Devices
Figure 18.1 Global Needle-free Injection Systems Market, till 2035 (USD Million)
Figure 18.2 Needle-free Injection Systems Market, till 2035: Conservative Scenario (USD Million)
Figure 18.3 Needle-free Injection Systems Market, till 2035: Optimistic Scenario (USD Million)
Figure 19.1 Needle-free Injection Systems Market: Distribution by Product Type
Figure 19.2 Needle-free Injection Systems Market for Fillable Devices, till 2035 (USD Million)
Figure 19.3 Needle-free Injection Systems Market for Prefilled Devices, till 2035 (USD Million)
Figure 20.1 Needle-free Injection Systems Market: Distribution by Actuation Mechanism
Figure 20.2 Needle-free Injection Systems Market for Spring-powered Devices, till 2035 (USD Million)
Figure 20.3 Needle-free Injection Systems Market for Compressed-gas Devices, till 2035 (USD Million)
Figure 20.4 Needle-free Injection Systems Market for Other Devices, till 2035 (USD Million)
Figure 21.1 Needle-free Injection Systems Market: Distribution by Product Usability
Figure 21.2 Needle-free Injection Systems Market for Reusable Devices, till 2035 (USD Million)
Figure 21.3 Needle-free Injection Systems Market for Disposable Devices, till 2035 (USD Million)
Figure 22.1 Needle-free Injection Systems Market: Distribution by Type of Load
Figure 22.2 Needle-free Injection Systems Market for Liquid-based Devices, till 2035 (USD Million)
Figure 22.3 Needle-free Injection Systems Market for Powder-based Devices, till 2035 (USD Million)
Figure 22.4 Needle-free Injection Systems Market for Projectile / Depot based Devices, till 2035 (USD Million)
Figure 23.1 Needle-free Injection Systems Market: Distribution by Route of Administration
Figure 23.2 Needle-free Injection Systems Market for Subcutaneous Route, till 2035 (USD Million)
Figure 23.3 Needle-free Injection Systems Market for Intramuscular Route, till 2035 (USD Million)
Figure 23.4 Needle-free Injection Systems Market for Intradermal Route, till 2035 (USD Million)
Figure 24.1 Needle-free Injection Systems Market: Distribution by Application Area
Figure 24.2 Needle-free Injection Systems Market for Insulin Delivery, till 2035 (USD Million)
Figure 24.3 Needle-free Injection Systems Market for Pain Management, till 2035 (USD Million)
Figure 24.4 Needle-free Injection Systems Market for Dermatology, till 2035 (USD Million)
Figure 24.5 Needle-free Injection Systems Market for Vaccination, till 2035 (USD Million)
Figure 25.1 Needle-free Injection Systems Market: Distribution by Geography
Figure 25.2 Needle-free Injection Systems Market in North America, till 2035 (USD Million)
Figure 25.3 Needle-free Injection Systems Market in the US, till 2035 (USD Million)
Figure 25.4 Needle-free Injection Systems Market in Canada, till 2035 (USD Million)
Figure 25.5 Needle-free Injection Systems Market in Europe, till 2035 (USD Million)
Figure 25.6 Needle-free Injection Systems Market in Germany, till 2035 (USD Million)
Figure 25.7 Needle-free Injection Systems Market in the UK, till 2035 (USD Million)
Figure 25.8 Needle-free Injection Systems Market in France, till 2035 (USD Million)
Figure 25.9 Needle-free Injection Systems Market in Italy, till 2035 (USD Million)
Figure 25.10 Needle-free Injection Systems Market in Spain, till 2035 (USD Million)
Figure 25.11 Needle-free Injection Systems Market in Asia-Pacific, till 2035 (USD Million)
Figure 25.12 Needle-free Injection Systems Market in China, till 2035 (USD Million)
Figure 25.13 Needle-free Injection Systems Market in India, till 2035 (USD Million)
Figure 25.14 Needle-free Injection Systems Market in Japan, till 2035 (USD Million)
Figure 25.15 Needle-free Injection Systems Market in Australia, till 2035 (USD Million)
Figure 25.16 Needle-free Injection Systems Market in Middle East and North Africa, till 2035 (USD Million)
Figure 25.17 Needle-free Injection Systems Market in Egypt, till 2035 (USD Million)
Figure 25.18 Needle-free Injection Systems Market in Saudi Arabia, till 2035 (USD Million)
Figure 25.19 Needle-free Injection Systems Market in Israel, till 2035 (USD Million)
Figure 25.20 Needle-free Injection Systems Market in Latin America, till 2035 (USD Million)
Figure 25.21 Needle-free Injection Systems Market in Brazil, till 2035 (USD Million)
Figure 25.22 Needle-free Injection Systems Market in Mexico, till 2035 (USD Million)
Figure 25.23 Needle-free Injection Systems Market in Argentina, till 2035 (USD Million)
Figure 26.1 Global Microneedle Devices Market, till 2035 (USD Million)
Figure 26.2 Microneedle Devices Market, till 2035: Conservative Scenario (USD Million)
Figure 26.3 Microneedle Devices Market, till 2035: Optimistic Scenario (USD Million)
Figure 27.1 Microneedle Devices Market: Distribution by Type of Microneedle
Figure 27.2 Microneedle Devices Market for Hollow Microneedles, till 2035 (USD Million)
Figure 27.3 Microneedle Devices Market for Solid Microneedles, till 2035 (USD Million)
Figure 27.4 Microneedle Devices Market for Dissolving Microneedles, till 2035 (USD Million)
Figure 27.5 Microneedle Devices Market for Coated Microneedles, till 2035 (USD Million)
Figure 28.1 Microneedle Devices Market: Distribution by Type of Material Used
Figure 28.2 Microneedle Devices Market for Polymer Microneedles, till 2035 (USD Million)
Figure 28.3 Microneedle Devices Market for Silicon Microneedles, till 2035 (USD Million)
Figure 28.4 Microneedle Devices Market for Metal Microneedles, till 2035 (USD Million)
Figure 28.5 Microneedle Devices Market for Ceramic Microneedles, till 2035 (USD Million)
Figure 29.1 Microneedle Devices Market: Distribution by Application Area
Figure 29.2 Microneedle Devices Market for Insulin Delivery, till 2035 (USD Million)
Figure 29.3 Microneedle Devices Market for Vaccination, till 2035 (USD Million)
Figure 29.4 Microneedle Devices Market for Pain Management, till 2035 (USD Million)
Figure 29.5 Microneedle Devices Market for Oncology, till 2035 (USD Million)
Figure 30.1 Microneedle Devices Market: Distribution by Type of Intervention
Figure 30.2 Microneedle Devices Market for Vaccines, till 2035 (USD Million)
Figure 30.3 Microneedle Devices Market for Therapeutic Agents, till 2035 (USD Million)
Figure 30.4 Microneedle Devices Market for Other Interventions, till 2035 (USD Million)
Figure 31.1 Microneedle Devices Market: Distribution by Geography
Figure 31.2 Microneedle Devices Market in North America, till 2035 (USD Million)
Figure 31.3 Microneedle Devices Market in the US, till 2035 (USD Million)
Figure 31.4 Microneedle Devices Market in Canada, till 2035 (USD Million)
Figure 31.5 Microneedle Devices Market in Europe, till 2035 (USD Million)
Figure 31.6 Microneedle Devices Market in Germany, till 2035 (USD Million)
Figure 31.7 Microneedle Devices Market in the UK, till 2035 (USD Million)
Figure 31.8 Microneedle Devices Market in France, till 2035 (USD Million)
Figure 31.9 Microneedle Devices Market in Italy, till 2035 (USD Million)
Figure 31.10 Microneedle Devices Market in Spain, till 2035 (USD Million)
Figure 31.11 Microneedle Devices Market in Asia-Pacific, till 2035 (USD Million)
Figure 31.12 Microneedle Devices Market in China, till 2035 (USD Million)
Figure 31.13 Microneedle Devices Market in India, till 2035 (USD Million)
Figure 31.14 Microneedle Devices Market in Japan, till 2035 (USD Million)
Figure 31.15 Microneedle Devices Market in Australia, till 2035 (USD Million)
Figure 31.16 Microneedle Devices Market in Middle East and North Africa, till 2035 (USD Million)
Figure 31.17 Microneedle Devices Market in Egypt, till 2035 (USD Million)
Figure 31.18 Microneedle Devices Market in Saudi Arabia, till 2035 (USD Million)
Figure 31.19 Microneedle Devices Market in Israel, till 2035 (USD Million)
Figure 31.20 Microneedle Devices Market in Latin America, till 2035 (USD Million)
Figure 31.21 Microneedle Devices Market in Brazil, till 2035 (USD Million)
Figure 31.22 Microneedle Devices Market in Argentina, till 2035 (USD Million)
Figure 31.23 Microneedle Devices Market in Mexico, till 2035 (USD Million)
Figure 32.1 Concluding Remarks: Needle-free Injection Systems: Market Landscape
Figure 32.2 Concluding Remarks: Microneedle Devices: Market Landscape
Figure 32.3 Concluding Remarks: Needle-free Injection Systems: Market Sizing and Opportunity Analysis
Figure 32.4 Concluding Remarks: Microneedle Devices: Market Sizing and Opportunity Analysis
Table 7.1 Needle-free Injection System Providers: Information on Year of Establishment, Company Size and Location of Headquarters (Region)
Table 7.2 List of Needle-free Injection Systems
Table 7.3 Needle-free Injection Systems: Information on Type of Actuation Mechanism
Table 7.4 Needle-free Injection Systems: Information on Route of Administration
Table 7.5 Needle-free Injection Systems: Information on Type of Formulation Administered
Table 7.6 Needle-free Injection Systems: Information on Type of Drug Delivered
Table 7.7 Needle-free Injection Systems: Information on Therapeutic Area
Table 7.8 Needle-free Injection Systems: Information on Usability
Table 8.1 Microneedle Device Providers: Information on Year of Establishment, Company Size and Location of Headquarters (Region)
Table 8.2 List of Microneedle Devices
Table 8.3 Microneedle Devices: Information on Stage of Development
Table 8.4 Microneedle Devices: Information on Type of Microneedle
Table 8.5 Microneedle Devices: Information on Type of Formulation Administered
Table 8.6 Microneedle Devices: Information on Route of Administration
Table 8.7 Microneedle Devices: Information on Therapeutic Area
Table 8.8 Microneedle Devices: Information on Type of Drug Delivered
Table 11.1 Marketed Molecules: Most Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.2 Marketed Molecules: Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.3 Marketed Molecules: Less Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.4 Marketed Molecules: Least Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.5 Clinical Drug Candidates (Biologics): Most Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.6 Clinical Drug Candidates (Biologics): Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.7 Clinical Drug Candidates (Biologics): Less Likely Candidates for Delivery via Needle-Free Injection Systems
Table 11.8 Clinical Drug Candidates (Biologics): Least Likely Candidates for Delivery via Needle-Free Injection Systems
Table 12.1 Marketed Molecules: Most Likely Candidates for Delivery via Microneedle Devices
Table 12.2 Marketed Molecules: Likely Candidates for Delivery via Microneedle Devices
Table 12.3 Marketed Molecules: Less Likely Candidates for Delivery via Microneedle Devices
Table 12.4 Marketed Molecules: Least Likely Candidates for Delivery via Microneedle Devices
Table 12.5 Clinical Drug Candidates (Biologics): Most Likely Candidates for Delivery via Microneedle Devices
Table 12.6 Clinical Drug Candidates (Biologics): Likely Candidates for Delivery via Microneedle Devices
Table 12.7 Clinical Drug Candidates (Biologics): Less Likely Candidates for Delivery via Microneedle Devices
Table 12.8 Clinical Drug Candidates (Biologics): Least Likely Candidates for Delivery via Microneedle Devices
Table 13.1 Antares Pharma: Company Snapshot
Table 13.2 Antares Pharma: Product Portfolio
Table 13.3 D’ Antonio Consultants International: Company Snapshot
Table 13.4 D’ Antonio Consultants International: Product Portfolio
Table 13.5 HNS International: Company Snapshot
Table 13.6 HNS International: Product Portfolio
Table 13.7 INOVIO Pharmaceuticals: Company Snapshot
Table 13.8 INOVIO Pharmaceuticals: Product Portfolio
Table 13.9 Medical International Technology: Company Snapshot
Table 13.10 Medical International Technology: Product Portfolio
Table 13.11 PharmaJet: Company Snapshot
Table 13.12 PharmaJet: Product Portfolio
Table 13.13 PharmaJet: Recent Developments and Future Outlook
Table 13.14 Zogenix: Company Snapshot
Table 13.15 Zogenix: Product Portfolio
Table 13.16 3M: Company Snapshot
Table 13.17 3M: Product Portfolio
Table 13.18 TheraJect: Company Snapshot
Table 13.19 TheraJect: Product Portfolio
Table 14.1 INJEX Pharma: Company Snapshot
Table 14.2 INJEX Pharma: Product Portfolio
Table 14.3 Debiotech: Company Snapshot
Table 14.4 Debiotech: Product Portfolio
Table 14.5 Micropoint Technologies: Company Snapshot
Table 14.6 Micropoint Technologies: Product Portfolio
Table 14.7 Nemaura Pharma: Company Snapshot
Table 14.8 Nemaura Pharma Product Portfolio
Table 15.1 Mika Medical: Company Snapshot
Table 15.2 Mika Medical: Product Portfolio
Table 15.3 QS Medical Technology (Quinovare): Company Snapshot
Table 15.4 QS Medical Technology (Quinovare): Product Portfolio
Table 15.5 QS Medical Technology (Quinovare): Recent Developments and Future Outlook
Table 15.6 INCYTO: Company Snapshot
Table 15.7 INCYTO: Product Portfolio
Table 15.8 NanoPass Technologies: Company Snapshot
Table 15.9 NanoPass Technologies: Product Portfolio
Table 33.1 Portal Instruments: Company Snapshot
Table 33.2 Vaxess Technologies: Company Snapshot
Table 33.3 Innoture: Company Snapshot
Table 34.1 Needle-free Injection System Providers: Distribution by Year of Establishment
Table 34.2 Needle-free Injection System Providers: Distribution by Company Size
Table 34.3 Needle-free Injection System Providers: Distribution by Location of Headquarters (Region)
Table 34.4 Needle-free Injection System Providers: Distribution by Location of Headquarters (Country)
Table 34.5 Needle-free Injection System Providers: Distribution by Company Size and Location of Headquarters (Region)
Table 34.6 Needle-free Injection Systems: Distribution by Type of Actuation Mechanism
Table 34.7 Needle-free Injection Systems: Distribution by Route of Administration
Table 34.8 Needle-free Injection Systems: Distribution by Type of Formulation Administered
Table 34.9 Needle-free Injection Systems: Distribution by Type of Drug Delivered
Table 34.10 Needle-free Injection Systems: Distribution by Therapeutic Area
Table 34.11 Needle-free Injection Systems: Distribution by Usability
Table 34.12 Needle-free Injection Systems: Distribution by Type of Formulation Administered and Actuation Mechanism
Table 34.13 Microneedle Device Providers: Distribution by Year of Establishment
Table 34.14 Microneedle Device Providers: Distribution by Company Size
Table 34.15 Microneedle Device Providers: Distribution by Location of Headquarters (Region)
Table 34.16 Microneedle Device Providers: Distribution by Location of Headquarters (Country)
Table 34.17 Microneedle Devices Providers: Distribution by Company Size and Location of Headquarters (Region)
Table 34.18 Microneedle Devices: Distribution by Stage of Development
Table 34.19 Microneedle Devices: Distribution by Type of Microneedle
Table 34.20 Microneedle Devices: Distribution by Type of Formulation Administered
Table 34.21 Microneedle Devices: Distribution by Route of Administration
Table 34.22 Microneedle Devices: Distribution by Therapeutic Area
Table 34.23 Microneedle Devices: Distribution by Type of Drug Delivered
Table 34.24 Microneedle Devices: Distribution by Type of Microneedle and Type of Formulation Administered
Table 34.25 Global Needle-free Injection Systems Market, till 2035: Base Scenario (USD Million)
Table 34.26 Needle-free Injection Systems Market, till 2035: Conservative Scenario (USD Million)
Table 34.27 Needle-free Injection Systems Market, till 2035: Optimistic Scenario (USD Million)
Table 34.28 Needle-free Injection Systems Market: Distribution by Product Type
Table 34.29 Needle-free Injection Systems Market for Fillable Devices, till 2035 (USD Million)
Table 34.30 Needle-free Injection Systems Market for Prefilled Devices, till 2035 (USD Million)
Table 34.31 Needle-free Injection Systems Market: Distribution by Actuation Mechanism
Table 34.32 Needle-free Injection Systems Market for Spring-powered Devices, till 2035 (USD Million)
Table 34.33 Needle-free Injection Systems Market for Compressed-gas Devices, till 2035 (USD Million)
Table 34.34 Needle-free Injection Systems Market for Other Devices, till 2035 (USD Million)
Table 34.35 Needle-free Injection Systems Market: Distribution by Product Usability
Table 34.36 Needle-free Injection Systems Market for Reusable Devices, till 2035 (USD Million)
Table 34.37 Needle-free Injection Systems Market for Disposable Devices, till 2035 (USD Million)
Table 34.38 Needle-free Injection Systems Market: Distribution by Type of Load
Table 34.39 Needle-free Injection Systems Market for Liquid-based Devices, till 2035 (USD Million)
Table 34.40 Needle-free Injection Systems Market for Powder-based Devices, till 2035 (USD Million)
Table 34.41 Needle-free Injection Systems Market for Projectile / depot based Devices, till 2035 (USD Million)
Table 34.42 Needle-free Injection Systems Market: Distribution by Route of Administration
Table 34.43 Needle-free Injection Systems Market for Subcutaneous Route of Administration, till 2035 (USD Million)
Table 34.44 Needle-free Injection Systems Market for Intramuscular Route of Administration, till 2035 (USD Million)
Table 34.45 Needle-free Injection Systems Market for Intradermal Route of Administration, till 2035 (USD Million)
Table 34.46 Needle-free Injection Systems Market: Distribution by Application Area
Table 34.47 Needle-free Injection Systems Market for Insulin Delivery, till 2035 (USD Million)
Table 34.48 Needle-free Injection Systems Market for Pain Management, till 2035 (USD Million)
Table 34.49 Needle-free Injection Systems Market for Dermatology, till 2035 (USD Million)
Table 34.50 Needle-free Injection Systems Market for Vaccination, till 2035 (USD Million)
Table 34.51 Needle-free Injection Systems Market: Distribution by Geography
Table 34.52 Needle-free Injection Systems Market in North America, till 2035 (USD Million)
Table 34.53 Needle-free Injection Systems Market in the US, till 2035 (USD Million)
Table 34.54 Needle-free Injection Systems Market in Canada, till 2035 (USD Million)
Table 34.55 Needle-free Injection Systems Market in Europe, till 2035 (USD Million)
Table 34.56 Needle-free Injection Systems Market in Germany, till 2035 (USD Million)
Table 34.57 Needle-free Injection Systems Market in the UK, till 2035 (USD Million)
Table 34.58 Needle-free Injection Systems Market in the France, till 2035 (USD Million)
Table 34.59 Needle-free Injection Systems Market in Italy, till 2035 (USD Million)
Table 34.60 Needle-free Injection Systems Market in Spain, till 2035 (USD Million)
Table 34.61 Needle-free Injection Systems Market in Asia-Pacific, till 2035 (USD Million)
Table 34.62 Needle-free Injection Systems Market in China, till 2035 (USD Million)
Table 34.63 Needle-free Injection Systems Market in India, till 2035 (USD Million)
Table 34.64 Needle-free Injection Systems Market in Japan, till 2035 (USD Million)
Table 34.65 Needle-free Injection Systems Market in Australia, till 2035 (USD Million)
Table 34.66 Needle-free Injection Systems Market in Middle East and North Africa, till 2035 (USD Million)
Table 34.67 Needle-free Injection Systems Market in Egypt, till 2035 (USD Million)
Table 34.68 Needle-free Injection Systems Market in Saudi Arabia, till 2035 (USD Million)
Table 34.69 Needle-free Injection Systems Market in Israel, till 2035 (USD Million)
Table 34.70 Needle-free Injection Systems Market in Latin America, till 2035 (USD Million)
Table 34.71 Needle-free Injection Systems Market in Brazil, till 2035 (USD Million)
Table 34.72 Needle-free Injection Systems Market in Mexico, till 2035 (USD Million)
Table 34.73 Needle-free Injection Systems Market in Argentina, till 2035 (USD Million)
Table 34.74 Global Microneedles Devices Market, till 2035: (USD Million)
Table 34.75 Microneedles Devices Market, till 2035: Conservative Scenario (USD Million)
Table 34.76 Microneedles Devices Market, till 2035: Optimistic Scenario (USD Million)
Table 34.77 Microneedles Devices Market: Distribution by Type of Microneedle Devices
Table 34.78 Microneedles Devices Market for Hollow Microneedles, till 2035 (USD Million)
Table 34.79 Microneedles Devices Market for Solid Microneedles, till 2035 (USD Million)
Table 34.80 Microneedles Devices Market for Dissolving Microneedles, till 2035 (USD Million)
Table 34.81 Microneedles Devices Market for Coated Microneedles, till 2035 (USD Million)
Table 34.82 Microneedles Devices Market: Distribution by Type of Material Used
Table 34.83 Microneedles Devices Market for Polymer Microneedles, till 2035 (USD Million)
Table 34.84 Microneedles Devices Market for Silicon Microneedles, till 2035 (USD Million)
Table 34.85 Microneedles Devices Market for Metal Microneedles, till 2035 (USD Million)
Table 34.86 Microneedles Devices Market for Ceramic Microneedles, till 2035 (USD Million)
Table 34.87 Microneedle Devices Market: Distribution by Application Area
Table 34.88 Microneedle Devices Market for Insulin Delivery, till 2035 (USD Million)
Table 34.89 Microneedle Devices Market for Vaccination, till 2035 (USD Million)
Table 34.90 Microneedle Devices Market for Pain Management, till 2035 (USD Million)
Table 34.91 Microneedle Devices Market for Oncology, till 2035 (USD Million)
Table 34.92 Microneedle Devices Market: Distribution by Type of Intervention
Table 34.93 Microneedle Devices Market for Vaccines, till 2035 (USD Million)
Table 34.94 Microneedle Devices Market for Therapeutic Agents, till 2035 (USD Million)
Table 34.95 Microneedle Devices Market for Other Interventions, till 2035 (USD Million)
Table 34.96 Microneedle Devices Market: Distribution by Geography
Table 34.97 Microneedle Devices Market in North America, till 2035 (USD Million)
Table 34.98 Microneedle Devices Market in the US, till 2035 (USD Million)
Table 34.99 Microneedle Devices Market in Canada, till 2035 (USD Million)
Table 34.100 Microneedle Devices Market in Europe, till 2035 (USD Million)
Table 34.101 Microneedle Devices Market in Germany, till 2035 (USD Million)
Table 34.102 Microneedle Devices Market in the UK, till 2035 (USD Million)
Table 34.103 Microneedle Devices Market in France, till 2035 (USD Million)
Table 34.104 Microneedle Devices Market in Italy, till 2035 (USD Million)
Table 34.105 Microneedle Devices Market in Spain, till 2035 (USD Million)
Table 34.106 Microneedle Devices Market in Asia-Pacific, till 2035 (USD Million)
Table 34.107 Microneedle Devices Market in China, till 2035 (USD Million)
Table 34.108 Microneedle Devices Market in India, till 2035 (USD Million)
Table 34.109 Microneedle Devices Market in Japan, till 2035 (USD Million)
Table 34.110 Microneedle Devices Market in Australia, till 2035 (USD Million)
Table 34.111 Microneedle Devices Market in Middle East and North Africa, till 2035 (USD Million)
Table 34.112 Microneedle Devices Market in Egypt, till 2035 (USD Million)
Table 34.113 Microneedle Devices Market in Saudi Arabia, till 2035 (USD Million)
Table 34.114 Microneedle Devices Market in Israel, till 2035 (USD Million)
Table 34.115 Microneedle Devices Market in Latin America, till 2035 (USD Million)
Table 34.116 Microneedle Devices Market in Brazil, till 2035 (USD Million)
Table 34.117 Microneedle Devices Market in Argentina, till 2035 (USD Million)
Table 34.118 Microneedle Devices Market in Mexico, till 2035 (USD Million)
Please reach out to our team for the details.